首頁 > 市場調查報告書 > 製藥

奈米技術 DDS

市場調查報告書

商品編碼

1339257

奈米醫學市場、份額、規模、趨勢、行業分析報告：按應用、按適應症、按分子類型、按地區、按細分市場、預測，2023-2032 年

Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2032

出版日期: 2023年07月23日 | 出版商:

Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據Polaris Market Research的最新研究，到2032年，全球奈米醫學市場預計將達到5,377.5億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

癌症和心血管疾病等慢性疾病的流行正在推動奈米藥物的需求。隨著人口老化以及高血壓和肥胖等疾病患者數量的增加，對創新和有針對性的治療方法的需求也隨之增加。例如，美國癌症協會估計，2022 年僅美國就會新增 190 萬癌症病例，並有 609,360 例癌症相關死亡。這凸顯了迫切需要包括奈米醫學在內的先進治療方法來應對這些醫療保健挑戰。

奈米醫學能夠實現標靶藥物輸送、改進的影像技術和個人化醫療方法，以改善治療結果。新藥物輸送技術的出現也促進了奈米醫學產業的擴張。奈米顆粒、奈米載體和其他奈米級藥物傳輸系統具有提高生物利用度、控制釋放和減少副作用等優點。藥物傳輸技術的這些進步吸引了製藥公司和醫療保健提供者的注意和投資。

政府的資助和支持對於推動奈米醫學市場至關重要。世界各國政府已經認識到奈米醫學徹底改變醫療保健的潛力，並正在提供財政支持、研究資助和監管支持，以加速奈米醫學產品的開發和商業化。增加政府資助和支持措施預計將促進學術界、工業界和研究機構之間的合作，從而對市場成長產生積極影響。例如，2022年8月，韓國生命科學基金宣布對Senda Biosciences投資超過1,400萬美元。此類投資代表了充滿希望的成長機會，並顯示了對奈米醫學產業未來的信心。

過去幾十年來，美國食品和藥物管理局 (FDA) 批准了大約 100 種奈米醫學應用和設備，極大地激發了人們對奈米技術醫療潛力日益增長的興趣。監管機構的這項驗證增強了人們對奈米醫學的信心，並刺激了該領域的進一步投資、研究和開發。人們越來越認識到奈米技術在推進醫學治療和療法中的作用，這被認為是醫學領域的突破，也是市場成長的驅動力。

奈米醫學市場報告亮點

現代貿易通路產業預計在預測期內將以大幅複合年增長率成長，因為它包括雜貨連鎖店、小型超市和大賣場等主要參與者。

體育用品商店佔收入的最大份額，這是由於體育用品商店中各種雪地摩托車的供應量不斷增加而推動的。

由於雪上運動活動的增加以及雪地摩托車的發展，預計亞太地區在預測期內將以顯著的複合年增長率增長。

主要發現
簡介
- 2019-2032 年奈米藥物市場評估（按地區）
奈米醫學市場 - 北美
- 北美：以適應症劃分的奈米醫學市場，2019-2032 年
- 北美：按分子類型劃分的奈米醫學市場，2019-2032 年
- 北美：奈米醫學市場，按應用劃分，2019-2032 年
- 美國奈米醫學市場
- 奈米醫學市場 - 加拿大
奈米醫學市場 - 歐洲
- 歐洲：奈米醫學市場，依適應症劃分，2019-2032 年
- 歐洲：奈米醫學市場，依分子類型，2019-2032 年
- 歐洲：奈米醫學市場，依應用劃分，2019-2032 年
- 奈米醫學市場 - 英國
- 奈米醫學市場 - 法國
- 奈米醫學市場 - 德國
- 奈米醫學市場 - 義大利
- 奈米醫學市場 - 西班牙
- 奈米醫學市場 - 荷蘭
- 奈米醫學市場 - 俄羅斯
奈米醫學市場 - 亞太地區
- 亞太地區：以適應症劃分的奈米醫學市場，2019-2032 年
- 亞太地區：奈米醫學市場，依分子類型，2019-2032 年
- 亞太地區：奈米醫學市場，按應用劃分，2019-2032 年
- 奈米醫學市場 - 中國
- 奈米醫學市場—印度
- 奈米醫學市場 - 馬來西亞
- 奈米醫學市場－日本
- 納米醫藥市場－印度尼西亞
- 奈米醫學市場－韓國
奈米醫學市場 - 中東和非洲
- 中東與非洲：奈米醫學市場，依適應症劃分，2019-2032 年
- 中東和非洲：奈米醫學市場，按分子類型，2019-2032 年
- 中東與非洲：奈米醫學市場，按應用劃分，2019-2032 年
- 奈米醫學市場－沙烏地阿拉伯
- 奈米醫學市場 - 阿拉伯聯合大公國
- 奈米醫學市場——以色列
- 奈米醫學市場 - 南非
奈米醫學市場 - 拉丁美洲
- 拉丁美洲：奈米醫學市場，依適應症劃分，2019-2032 年
- 拉丁美洲：奈米醫學市場，依分子類型，2019-2032 年
- 拉丁美洲：奈米醫學市場，按應用劃分，2019-2032 年
- 奈米醫學市場 - 墨西哥
- 奈米醫學市場 - 巴西
- 奈米醫學市場——阿根廷

第九章競爭態勢

擴張與收購分析
- 放大
- 收購
夥伴關係/協作/協議/揭露

第十章公司簡介

GE Healthcare
Abbott Laboratories
CombiMatrix Corporation
Celgene
Nanospectra Biosciences
Johnson & Johnson
Mallinckrodt Pharmaceuticals
Merck
Pfizer
Teva Pharmaceutical
Arrowhead Pharmaceuticals

簡介目錄圖表

Product Code: PM3637

The global nanomedicine market size is expected to reach USD 537.75 billion by 2032, according to a new study by Polaris Market Research. The report "Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The prevalence of chronic diseases, including cancer and cardiovascular diseases, is driving the demand for nanomedicine. With an aging population and an increase in patients with conditions such as high blood pressure and obesity, the need for innovative and targeted treatment approaches has become more critical. For example, according to the American Cancer Society, in 2022, it was estimated that there would be 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States alone. This highlights the urgent need for advanced therapies, including nanomedicine, to address these healthcare challenges.

Nanomedicine enables targeted drug delivery, improved imaging techniques, and personalized medicine approaches, enhancing treatment outcomes. The emergence of novel drug-delivery technologies also contributes to the nanomedicine industry's expansion. Nanoparticles, nanocarriers, and other nanoscale drug delivery systems offer advantages such as improved bioavailability, controlled release, and reduced side effects. These advancements in drug delivery technology have attracted attention and investment from pharmaceutical companies and healthcare providers.

Government funding and support are crucial in driving the nanomedicine market forward. Governments worldwide recognize the potential of nanomedicine in revolutionizing healthcare and are providing financial assistance, research grants, and regulatory support to encourage the development and commercialization of nanomedicine products. The increase in government funding and support initiatives is anticipated to positively impact market growth, fostering collaboration between academia, industry, and research institutions. For instance, in August 2022, South Korea's Life Science Fund announced an investment of over USD 14 Mn in Senda Biosciences. Such investments indicate promising growth opportunities and signify confidence in the future of the nanomedicine industry.

The authorization of approximately 100 nanomedicine applications and devices by the US Food and Drug Administration (FDA) over the past few decades has significantly contributed to the increasing interest in nanotechnology's medical potential. This validation by regulatory authorities has boosted confidence in nanomedicine and stimulated further investment, research, and development in the field. The growing recognition of nanotechnology's role in advancing medical treatments and therapies is considered a breakthrough in the medical field, driving market growth.

Nanomedicine Market Report Highlights

The modern trade channels segment is anticipated to grow at a significant CAGR over the forecast period owing to they include bigger players like grocery chains, mini-marts, and hypermarkets.

Sports variety stores accounted for largest revenue share which is accelerated by the rising availability of various snow scooters in the sports stores.

Asia-Pacific is expected to grow at a considerable CAGR over the projected period on account of the rising snow sports activities as well as the development of snow scooters.

The global players include: Crayon Motors, Jiangsu Youmota Technology, NSG Products, Railz LLC, Shanghai Puyi Industrial, Lakeside Collection, Eretic Inc., and Wuxi Copower Technology.

Polaris Market Research has segmented the nanomedicine market report based on application, indication, molecule type, and region:

Nanomedicine, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Therapeutics
In-vitro Diagnostics
Drug Delivery
In-vivo Imaging
Implants

Nanomedicine, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

Clinical Oncology
Infectious Diseases
Clinical Cardiology
Orthopedics
Others

Nanomedicine, Molecule Type Outlook (Revenue - USD Billion, 2019 - 2032)

Nanoparticles
Metal & Metal Oxide Nanoparticles
Liposomes
Polymers & Polymer Drug Conjugates
Hydrogel Nanoparticles
Dendrimers
Inorganic Nanoparticles
Nanoshells
Nanotubes
Nanodevices

Nanomedicine, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Nanomedicine Market Insights

4.1. Nanomedicine Market - Molecule Type Snapshot
4.2. Nanomedicine Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increase in demand for renewable sources of energy
  - 4.2.1.2. Rise in demand for electricity consumption
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High initial costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Nanomedicine Market Molecule Type Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Nanomedicine Market, by Indication

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
5.3. Clinical Oncology
- 5.3.1. Global Nanomedicine Market, by Clinical Oncology, by Region, 2019-2032 (USD Billion)
5.4. Infectious diseases
- 5.4.1. Global Nanomedicine Market, by Infectious diseases, by Region, 2019-2032 (USD Billion)
5.5. Clinical Cardiology
- 5.5.1. Global Nanomedicine Market, by Clinical Cardiology, by Region, 2019-2032 (USD Billion)
5.6. Orthopedics
- 5.6.1. Global Nanomedicine Market, by Orthopedics, by Region, 2019-2032 (USD Billion)
5.7. Others
- 5.7.1. Global Nanomedicine Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Nanomedicine Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Nanomedicine Market, by Application, 2019-2032 (USD Billion)
6.3. Therapeutics
- 6.3.1. Global Nanomedicine Market, by Therapeutics, by Region, 2019-2032 (USD Billion)
6.4. in-vitro Diagnostics
- 6.4.1. Global Nanomedicine Market, by in-vitro Diagnostics, by Region, 2019-2032 (USD Billion)
6.5. Drug Delivery
- 6.5.1. Global Nanomedicine Market, by Drug Delivery, by Region, 2019-2032 (USD Billion)
6.6. In-vivo Imaging
- 6.6.1. Global Nanomedicine Market, by In-vivo Imaging, by Region, 2019-2032 (USD Billion)
6.7. Implants
- 6.7.1. Global Nanomedicine Market, by Implants, by Region, 2019-2032 (USD Billion)

7. Global Nanomedicine Market, by Molecule Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
7.3. Nanoparticles
- 7.3.1. Global Nanomedicine Market, by Nanoparticles, By Region, 2019-2032 (USD Billion)
- 7.3.2. Metal & Metal Oxide Nanoparticles
  - 7.3.2.1. Global Nanomedicine Market, by Metal & Metal Oxide Nanoparticles, By Region, 2019-2032 (USD Billion)
- 7.3.3. Liposomes
  - 7.3.3.1. Global Nanomedicine Market, by Liposomes, By Region, 2019-2032 (USD Billion)
- 7.3.4. Polymers & polymer drug conjugates
  - 7.3.4.1. Global Nanomedicine Market, by Polymers & polymer drug conjugates, By Region, 2019-2032 (USD Billion)
- 7.3.5. Hydrogel Nanoparticles
  - 7.3.5.1. Global Nanomedicine Market, by Hydrogel Nanoparticles, By Region, 2019-2032 (USD Billion)
- 7.3.6. Dendrimers
  - 7.3.6.1. Global Nanomedicine Market, by Dendrimers, By Region, 2019-2032 (USD Billion)
- 7.3.7. Inorganic Nanoparticles
  - 7.3.7.1. Global Nanomedicine Market, by Inorganic Nanoparticles, By Region, 2019-2032 (USD Billion)
7.4. Nanoshells
- 7.4.1. Global Nanomedicine Market, by Nanoshells, By Region, 2019-2032 (USD Billion)
7.5. Nanotubes
- 7.5.1. Global Nanomedicine Market, by Nanotubes, By Region, 2019-2032 (USD Billion)
7.6. Nanodevices
- 7.6.1. Global Nanomedicine Market, by Nanodevices, By Region, 2019-2032 (USD Billion)

8. Global Nanomedicine Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Nanomedicine Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Nanomedicine Market - North America
- 8.3.1. North America: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.3.2. North America: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.3.3. North America: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.3.4. Nanomedicine Market - U.S.
  - 8.3.4.1. U.S.: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.3.4.2. U.S.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.3.4.3. U.S.: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.3.5. Nanomedicine Market - Canada
  - 8.3.5.1. Canada: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.3.5.2. Canada.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.3.5.3. Canada: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.4. Nanomedicine Market - Europe
- 8.4.1. Europe: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.4.3. Europe: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.4. Nanomedicine Market - UK
  - 8.4.4.1. UK: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.4.2. UK.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.4.3. UK: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.5. Nanomedicine Market - France
  - 8.4.5.1. France: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.5.2. France.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.5.3. France: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.6. Nanomedicine Market - Germany
  - 8.4.6.1. Germany: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.6.2. Germany.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.6.3. Germany: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.7. Nanomedicine Market - Italy
  - 8.4.7.1. Italy: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.7.2. Italy.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.7.3. Italy: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.8. Nanomedicine Market - Spain
  - 8.4.8.1. Spain: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.8.2. Spain.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.8.3. Spain: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.9. Nanomedicine Market - Netherlands
  - 8.4.9.1. Netherlands: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.9.2. Netherlands.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.9.3. Netherlands: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.10. Nanomedicine Market - Russia
  - 8.4.10.1. Russia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.10.2. Russia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.10.3. Russia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.5. Nanomedicine Market - Asia Pacific
- 8.5.1. Asia Pacific: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.4. Nanomedicine Market - China
  - 8.5.4.1. China: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.4.2. China.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.4.3. China: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.5. Nanomedicine Market - India
  - 8.5.5.1. India: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.5.2. India.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.5.3. India: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.6. Nanomedicine Market - Malaysia
  - 8.5.6.1. Malaysia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.6.2. Malaysia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.6.3. Malaysia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.7. Nanomedicine Market - Japan
  - 8.5.7.1. Japan: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.7.2. Japan.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.7.3. Japan: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.8. Nanomedicine Market - Indonesia
  - 8.5.8.1. Indonesia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.8.2. Indonesia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.8.3. Indonesia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.9. Nanomedicine Market - South Korea
  - 8.5.9.1. South Korea: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.9.2. South Korea.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.9.3. South Korea: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.6. Nanomedicine Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.4. Nanomedicine Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.4.2. Saudi Arabia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.5. Nanomedicine Market - UAE
  - 8.6.5.1. UAE: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.5.2. UAE.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.5.3. UAE: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.6. Nanomedicine Market - Israel
  - 8.6.6.1. Israel: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.6.2. Israel.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.6.3. Israel: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.7. Nanomedicine Market - South Africa
  - 8.6.7.1. South Africa: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.7.2. South Africa.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.7.3. South Africa: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.7. Nanomedicine Market - Latin America
- 8.7.1. Latin America: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.7.4. Nanomedicine Market - Mexico
  - 8.7.4.1. Mexico: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.7.4.2. Mexico.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.7.4.3. Mexico: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.7.5. Nanomedicine Market - Brazil
  - 8.7.5.1. Brazil: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.7.5.2. Brazil.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.7.5.3. Brazil: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.7.6. Nanomedicine Market - Argentina
  - 8.7.6.1. Argentina: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.7.6.2. Argentina.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.7.6.3. Argentina: Nanomedicine Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. GE Healthcare
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Abbott Laboratories
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. CombiMatrix Corporation
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Celgene
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Nanospectra Biosciences
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Johnson & Johnson
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Mallinckrodt Pharmaceuticals
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Merck
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Pfizer
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Teva Pharmaceutical
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Arrowhead Pharmaceuticals
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 2 Global Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 3 Global Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 4 Waste to Energy Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 5 North America: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 6 North America: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 7 North America: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 8 U.S.: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 9 U.S.: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 10 U.S.: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 11 Canada: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 12 Canada: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 13 Canada: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 14 Europe: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 15 Europe: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 16 Europe: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 17 UK: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 18 UK: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 19 UK: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 20 France: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 21 France: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 22 France: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 23 Germany: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 24 Germany: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 25 Germany: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 26 Italy: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 27 Italy: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 28 Italy: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 29 Spain: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 30 Spain: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 31 Spain: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 32 Netherlands: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 33 Netherlands: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 34 Netherlands: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 35 Russia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 36 Russia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 37 Russia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 38 Asia Pacific: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 39 Asia Pacific: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 40 Asia Pacific: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 41 China: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 42 China: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 43 China: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 44 India: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 45 India: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 46 India: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 47 Malaysia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 48 Malaysia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 49 Malaysia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 50 Japan: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 51 Japan: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 52 Japan: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 53 Indonesia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 54 Indonesia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 55 Indonesia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 56 South Korea: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 57 South Korea: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 58 South Korea: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 59 Middle East & Africa: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 60 Middle East & Africa: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 61 Middle East & Africa: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 62 Saudi Arabia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 63 Saudi Arabia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 64 Saudi Arabia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 65 UAE: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 66 UAE: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 67 UAE: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 68 Israel: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 69 Israel: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 70 Israel: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 71 South Africa: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 72 South Africa: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 73 South Africa: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 74 Latin America: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 75 Latin America: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 76 Latin America: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 77 Mexico: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 78 Mexico: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 79 Mexico: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 80 Brazil: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 81 Brazil: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 82 Brazil: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 83 Argentina: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 84 Argentina: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 85 Argentina: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Waste to Energy Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Application
Figure 7. Global Waste to Energy Market, by Application, 2022 & 2032 (USD Billion)
Figure 8. Market by Waste Type
Figure 9. Global Waste to Energy Market, by Waste Type, 2022 & 2032 (USD Billion)
Figure 10. Market by Technology
Figure 11. Global Waste to Energy Market, by Technology, 2022 & 2032 (USD Billion)
Figure 12. Waste to Energy Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 13. Strategic Analysis - Waste to Energy Market